首页 | 本学科首页   官方微博 | 高级检索  
检索        

精子畸形率对卵胞浆内单精子注射(ICSI)临床结局的影响
引用本文:王国贺,郭艺红,孙莹璞,苏迎春,金海霞,王杨.精子畸形率对卵胞浆内单精子注射(ICSI)临床结局的影响[J].生殖与避孕,2011,31(4):241-245.
作者姓名:王国贺  郭艺红  孙莹璞  苏迎春  金海霞  王杨
作者单位:郑州大学第一附属医院生殖中心,郑州,450052
摘    要:目的:分析畸形精子行卵胞浆内单精子注射(ICSI)的临床结局。方法:回顾性分析因男性因素行ICSI治疗的239个新鲜取卵周期。根据精子形态学分析结果将研究对象分为:精子形态正常组(A组)、非极重度畸形精子症组(B组)和极重度畸形精子症组(C组),比较3组的受精率、卵裂率、优质胚胎率、胚胎种植率及临床妊娠率、流产率、异位妊娠率和多胎妊娠率。结果:A、B组在受精率、卵裂率、优质胚胎率与C组有统计学差异(分别为80.20%、81.40%和67.60%;94.91%、93.42%和79.91%;63.87%、59.30%和54.29%)(P<0.05);3组的胚胎种植率、临床妊娠率、流产率、异位妊娠率、多胎妊娠率均无统计学差异(分别为26.3%、25.6%和24.2%;42.28%、45.00%和42.86%;7.94%、7.40%和25.00%;4.76%、3.70%和8.33%;31.75%、18.52%和25.00%)(P>0.05);而C组内手术取精(PESA/TESA)亚组的卵裂率低于体外排精亚组,差异有统计学意义(86.72%vs 76.11%,P<0.05)。结论:采用畸形精子行ICSI的不育患者同样可获得理想的临床结局。

关 键 词:畸形精子  卵胞浆内单精子注射(ICSI)  临床结局

Impact of Sperm Malformation Rate on ICSI Clinical Outcomes
Guo-he WANG,Yi-hong GUO,Ying-pu SUN,Ying-chun SU,Hai-xia JIN,Yang WANG.Impact of Sperm Malformation Rate on ICSI Clinical Outcomes[J].Reproduction and Contraception,2011,31(4):241-245.
Authors:Guo-he WANG  Yi-hong GUO  Ying-pu SUN  Ying-chun SU  Hai-xia JIN  Yang WANG
Institution:Guo-he WANG,Yi-hong GUO,Ying-pu SUN,Ying-chun SU,Hai-xia JIN,Yang WANG(Reproductive Medical Center of the First Affiliated Hospital of Zhengzhou University,Zhengzhou,450052)
Abstract:Objective:To evaluate the efficacy of intracytoplasmic sperm injection(ICSI) in the treatment for teratospermia.Methods:A total of 239 cycles received ICSI because of male factors was analyzed by a retrospective study.They were divided into 3 groups:group A(normal sperm forms group),group B(not severe teratospermia group) and group C(severe teratospermia group).All the infertility patients were diagnosed by sperm morphology before ICSI.The rates of fertilization,cleavage,good quality embryos,embryo implanta...
Keywords:teratospermia  intracytoplasmic sperm injection  outcomes  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号